论文部分内容阅读
Objective: Assess whether and to what extent thyroid function is affected in pregnant women with early and severe hypertensive disorders and in their newborns. METHODS: Patients were 80 women with preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome or gestational hypertension combined with fetal growth restriction in the 24th to 34th week of singleton pregnancies. Maternal thyroid hormone levels and thyroid peroxidase antibodies were determined at admission and 3 months postpartum. Neonatal levels were determined from cord blood at delivery. Maternal hypothyroxinemia was defined as free T4 (fT4) value below 9 pM. RESULTS: At admission 26 (33%) women in the study group had fT4 levels below 9 pM, with spontaneous normalization during pregnancy. There were no statistically significant differences between thyroid hormone values in women in the study group and 10 normotensive pregnant women in their third trimester. Three months postpartum, 97.5%of patients had normal thyroid hormone levels. Thyroid peroxidase antibodies were elevated in 10%of women postpartum. Their infants, born at a median gestational age of 30 6/7 weeks, had lower cord blood fT 4 and thyroid-stimulating hormone values compared with preterm infants of the comparison group, appropriate for gestational age. Cord blood fT4 had no correlation with gestational age or maternal fT 4, but there was a significant correlation of cord blood fT 4 with umbilical artery pH. CONCLUSION: Women with severe hypertensive disorders of pregnancy may have transiently lower fT4 levels, without evidence of a thyroid disorder. Their neonates have lower fT4 levels at birth unrelated to maternal fT4, but related to prenatal acidosis.
METHODS: Patients were 80 women with preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome or gestational hypertension combined with fetal growth restriction in the 24th to 34th week of singleton pregnancies. Maternal thyroid hormone levels and thyroid peroxidase antibodies were determined at admission and 3 months postpartum. Neonatal levels were determined from cord blood at delivery. Maternal hypothyroxinemia was defined as free T4 (fT4 There were no statistically significant differences between thyroid hormone values in women in the study group and 10 normotensive pregnant women in their third trimester. Three months postpartum, 97.5% of patients had Thyroid peroxidase antibodies were elevated in 10% of women postpartum. Their infants, born at a median gestational age of 30 6/7 weeks, had lower cord blood fT 4 and thyroid-stimulating hormone values compared with preterm infants of the comparison group, appropriate for gestational age. Cord blood fT4 had no correlation with gestational age or maternal fT 4, but there was a significant correlation of cord blood fT 4 with umbilical artery pH. CONCLUSION: Women with severe hypertensive disorders of pregnancy may have transiently lower fT4 levels, without evidence of a thyroid disorder. Their neonates have lower fT4 levels at birth unrelated to maternal fT4, but related to prenatal acidosis.